0001104659-23-062815.txt : 20230519 0001104659-23-062815.hdr.sgml : 20230519 20230519200818 ACCESSION NUMBER: 0001104659-23-062815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230519 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marquet Magda CENTRAL INDEX KEY: 0001631486 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40363 FILM NUMBER: 23942136 MAIL ADDRESS: STREET 1: ALTHEADX INC. STREET 2: 3550 DUNHILL STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcode Therapeutics, Inc. CENTRAL INDEX KEY: 0001829635 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811065054 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-301-6857 MAIL ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 4 1 tm2316383-5_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-05-19 0 0001829635 Transcode Therapeutics, Inc. RNAZ 0001631486 Marquet Magda C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109 1 0 0 0 0 Stock Option (right to buy) 0.2834 2023-05-19 4 A 0 45000 0.00 A 2033-05-18 Common Stock 45000 45000 D The shares subject to this option shall vest and become exercisable in full on December 31, 2023, subject to the Reporting Person's continued service at such time. /s/ Thomas A. Fitzgerald, as Attorney-in-Fact 2023-05-19